Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhaled drug delivery for the targeted treatment of asthma
Allison Boboltz, Sahana Kumar, Gregg A. Duncan
Advanced Drug Delivery Reviews (2023) Vol. 198, pp. 114858-114858
Closed Access | Times Cited: 20

Showing 20 citing articles:

Protein Coronas Derived from Mucus Act as Both Spear and Shield to Regulate Transferrin Functionalized Nanoparticle Transcellular Transport in Enterocytes
Dan Yang, Yu‐Qi Feng, Ying Yuan, et al.
ACS Nano (2024) Vol. 18, Iss. 10, pp. 7455-7472
Closed Access | Times Cited: 18
Optimization, In Vitro, and In Silico Characterization of Theophylline Inhalable Powder Using Raffinose-Amino Acid Combination as Fine Co-Spray-Dried Carriers
Petra Party, Lomass Soliman, Attila Nagy, et al.
Pharmaceutics (2025) Vol. 17, Iss. 4, pp. 466-466
Open Access | Times Cited: 1
Integrated transcriptomics and network pharmacology to reveal the mechanism of Physochlainae Radix in the treatment of asthma
Jin‐Yan Tan, Jianing Zhang, Weidong Yang, et al.
Phytomedicine (2025) Vol. 139, pp. 156470-156470
Closed Access
Innovative approaches to asthma treatment: harnessing nanoparticle technology
Vishal H. Goswami, Kushneet Kaur Sodhi, Chandra Kant Singh
Discover Nano (2025) Vol. 20, Iss. 1
Open Access
AAV-mediated MUC5AC siRNA delivery to prevent mucociliary dysfunction in asthma
Sahana Kumar, Maria Corkran, Yahya Cheema, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Allergy Treatment: A Comprehensive Review of Nanoparticle-based Allergen Immunotherapy
Mabrouk Abo-Zaid, Reem M. Elsapagh, Nourhan S. Sultan, et al.
Frontiers in Bioscience-Landmark (2025) Vol. 30, Iss. 3
Open Access
Targeted Drug Delivery System for Pulmonary Fibrosis: Design and Development of Biomaterials
Jinsha Liu, Zifeng Pan, Aatif Khan, et al.
BIO Integration (2025) Vol. 6, Iss. 1
Open Access
On the path to predicting immune responses in the lung: Modeling the pulmonary innate immune system at the air-liquid interface (ALI)
Jodi Graf, Michael Trautmann-Rodriguez, Simone Sabnis, et al.
European Journal of Pharmaceutical Sciences (2023) Vol. 191, pp. 106596-106596
Open Access | Times Cited: 9
Site-specific inhibition of neutrophilic inflammation by low-dose nanotherapy for immunoregulatory treatment of asthma
Lanlan Li, Yongchang Ma, Yi Hu, et al.
Nano Today (2023) Vol. 52, pp. 101957-101957
Closed Access | Times Cited: 8
Targeting type I PRMTs as promising targets for the treatment of pulmonary disorders: Asthma, COPD, lung cancer, PF, and PH
Shuyan Zhou, Qiangsheng Zhang, Honglin Yang, et al.
Life Sciences (2024) Vol. 342, pp. 122538-122538
Closed Access | Times Cited: 2
A review of the safety profile, antioxidant, anti-inflammatory, and bronchorelaxant activities of Waltheria indica Linn (Malvaceae): A potential antiasthmatic phytomedicine
Zakaline Yabré, Raïnatou Boly, Raogo Ouédraogo, et al.
Heliyon (2024) Vol. 10, Iss. 12, pp. e32402-e32402
Open Access | Times Cited: 2
Novel strategies in systemic and local administration of therapeutic monoclonal antibodies
Monika Prašnikar, Maja Bjelošević Žiberna, Mirjam Gosenca Matjaž, et al.
International Journal of Pharmaceutics (2024) Vol. 667, pp. 124877-124877
Open Access | Times Cited: 2
LungVis 1.0: an automatic AI-powered 3D imaging ecosystem unveils spatial profiling of nanoparticle delivery and acinar migration of lung macrophages
Lin Yang, Qiongliang Liu, Pramod Kumar, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
A bio-adhesion nanogel particle as an anti-inflammation agent for efficient aerosol inhalation therapy to asthma
Yibing Chen, Jingyi Hou, Xiaoyue Yue, et al.
Materials & Design (2024) Vol. 239, pp. 112734-112734
Open Access | Times Cited: 1
Understanding the role of swirling flow in dry powder inhalers implications for design considerations and pulmonary delivery
Jiale Chen, Yuqing Ye, Qingliang Yang, et al.
Journal of Controlled Release (2024) Vol. 373, pp. 410-425
Open Access | Times Cited: 1
Enhancing peptide and PMO delivery to mouse airway epithelia by chemical conjugation with the amphiphilic peptide S10
Maud Auger, Luis Sorroza-Martinez, Nadine Brahiti, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 3, pp. 102290-102290
Open Access | Times Cited: 1
Reshaping respiratory care: potential advances in inhaled pharmacotherapy in asthma
Boudewijn J.H. Dierick, Amber A. Eikholt, Susanne J. van de Hei, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 11, pp. 1507-1516
Closed Access | Times Cited: 1
Emerging Voices in Drug Delivery – Breaking Barriers (Issue 1)
Juliane Nguyen, Shawn C. Owen
Advanced Drug Delivery Reviews (2024) Vol. 208, pp. 115273-115273
Closed Access
Inhaled combined antibacterials against biofilm-forming antibiotic-resistant bacteria for the management of pulmonary bacterial infections
Ruwani K. Suraweera, Kirsten Spann, Timothy J. Wells, et al.
Journal of Drug Delivery Science and Technology (2024), pp. 106555-106555
Open Access
Diagnostic value of IgE, fractional of exhaled nitric oxide, and peripheral blood eosinophils in adult bronchial asthma and their relationship with disease severity
Liping Fang, Yan Shen, Tao Huang, et al.
American Journal of Translational Research (2024) Vol. 16, Iss. 12, pp. 7521-7529
Closed Access
Page 1

Scroll to top